###BASE_URL###

GENET-news

To stay informed you can subscribe to the GENET-news list.

 

2007-05-09 |

Genetically modified chicory brings hope to African malaria patients

Dafra Pharma International NV has commissioned Plant Research International (PRI) to start new research to optimize the production method of artemisinin via genetically modified chicory plants. This research should result in inexpensive, large-scale production of artemisinin under controllable conditions. [...] it must be the objective of Dafra Pharma International NV to achieve inexpensive, large-scale industrial production of artemisinin under controllable conditions via the root of the chicory plant in three to five years time. In the future this new inexpensive raw material should enable Dafra Pharma International NV to place its ACTs on the market for half a dollar per adult antimalarial treatment.

Overview

News

2007-05-09 |

Genetically modified chicory brings hope to African malaria patients

Dafra Pharma International NV has commissioned Plant Research International (PRI) to start new research to optimize the production method of artemisinin via genetically modified chicory plants. This research should result in inexpensive, large-scale production of artemisinin under controllable conditions. [...] it must be the objective of Dafra Pharma International NV to achieve inexpensive, large-scale industrial production of artemisinin under controllable conditions via the root of the chicory plant in three to five years time. In the future this new inexpensive raw material should enable Dafra Pharma International NV to place its ACTs on the market for half a dollar per adult antimalarial treatment.

Home: GENET

GENET-news & GENET-forum

GENET-news is providing a daily news service on a range of topics regarding genetic engineering. We are screening the worldwide English news, press releases and other publications to provide you with a strategic selection of information. GENET-news enables you to stay informed about all aspects of the global controversy around GE technologies and GE organisms. You can subscribe by  email.

The GENET-forum list provides you with additional background information and more voluminous reports. It is only open for GENET members. Please contact the  coordinator for membership and subscription.